Published in Cancer on November 01, 1996
Genomic instability influences the transcriptome and proteome in endometrial cancer subtypes. Mol Cancer (2011) 0.83
Biomarkers in cervical cancer. Biomark Insights (2007) 0.81
Biomarkers in endometrial cancer: Possible clinical applications (Review). Oncol Lett (2012) 0.80
Association between RCAS1 expression and clinical outcome in uterine endometrial cancer. Br J Cancer (2003) 0.77
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30
Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med (2013) 13.90
Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A (1996) 10.94
Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology (1997) 10.08
Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science (1997) 6.60
Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med (1998) 5.66
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA (1992) 4.31
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA (1997) 3.80
Stressful life events and Graves' disease. Lancet (1991) 3.63
Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med (1999) 3.31
Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst (1999) 3.13
Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst (1998) 3.10
Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst (1996) 2.71
Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology (1993) 2.64
The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer (2000) 2.58
Positive cervical smear with subsequent normal colposcopy and histology--frequency of CIN in a long-term follow-up. Gynecol Oncol (1994) 2.56
Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol Pharmacol (1998) 2.55
Strategies for global control of cervical cancer. Int J Cancer (1995) 2.52
Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits. J Biol Chem (1985) 2.47
Increasing cancer risk in younger birth cohorts in Sweden. Lancet (1993) 2.39
Testicular cancer in nine northern European countries. Int J Cancer (1994) 2.32
Estrogen receptors alpha and beta in the rodent mammary gland. Proc Natl Acad Sci U S A (2000) 2.24
The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study. Eur J Clin Nutr (2007) 2.21
Cell cycle-dependent regulation of mammalian ribonucleotide reductase. The S phase-correlated increase in subunit M2 is regulated by de novo protein synthesis. J Biol Chem (1984) 2.19
No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut (2000) 2.16
A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc Natl Acad Sci U S A (2001) 2.12
Survival in breast cancer diagnosed between mammographic screening examinations. Lancet (1986) 2.12
Soccer injuries in adolescents. Am J Sports Med (1979) 2.12
S-phase-specific expression of mammalian ribonucleotide reductase R1 and R2 subunit mRNAs. Biochemistry (1990) 2.07
Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol (1989) 2.07
Response rate to mailed epidemiologic questionnaires: a population-based randomized trial of variations in design and mailing routines. Am J Epidemiol (1998) 2.06
Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst (1997) 1.98
Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer (1999) 1.98
Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med (1998) 1.91
Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia (2006) 1.90
Observed and relative survival after aortic valve replacement. J Am Coll Cardiol (2000) 1.86
Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer (1998) 1.86
Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med (2000) 1.83
Increasing survival trend after cancer diagnosis in Sweden: 1960-1984. J Natl Cancer Inst (1989) 1.82
Surgical anatomy of human parathyroid glands. Surgery (1984) 1.81
Early detection of malignancy in ulcerative colitis. A flow-cytometric DNA study. Cancer (1984) 1.80
Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway. Lancet (1986) 1.79
Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med (1986) 1.79
The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol Endocrinol (1999) 1.74
Risk factors for oesophageal cancer in northeast China. Int J Cancer (1994) 1.73
Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst (1999) 1.73
Smoking and colorectal cancer: a 20-year follow-up study of Swedish construction workers. J Natl Cancer Inst (1996) 1.71
Hormone-sensitive lipase: sequence, expression, and chromosomal localization to 19 cent-q13.3. Science (1988) 1.69
Long-term follow-up of morbidity and mortality after aortic valve replacement with a mechanical valve prosthesis. Eur Heart J (2000) 1.68
Sternal wound complications--incidence, microbiology and risk factors. Eur J Cardiothorac Surg (1997) 1.66
A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer. Eur J Cancer (2012) 1.64
Cigarette smoking and neoplasia of the uterine cervix: smoke constituents in cervical mucus. N Engl J Med (1985) 1.62
[111In-DTPA-D-Phe1]octreotide scintigraphy in patients with carcinoid tumours: the predictive value for somatostatin analogue treatment. Eur J Endocrinol (1994) 1.61
Prognostic significance of the microvascular count in colorectal cancer. J Clin Oncol (1996) 1.59
Mammographic screening for breast cancer. What cancers do we find? Eur J Cancer (1997) 1.58
Survival in renal cell carcinoma-a randomized evaluation of tamoxifen vs interleukin 2, alpha-interferon (leucocyte) and tamoxifen. Br J Cancer (1998) 1.57
Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979. Surgery (1987) 1.56
A randomized controlled study comparing pain experience between a newly designed needle with a thin tip and a standard needle for oocyte aspiration. Hum Reprod (2011) 1.56
Airborne cell analysis. Anal Chem (2000) 1.51
International incidence rates of invasive cervical cancer before cytological screening. Int J Cancer (1997) 1.50
Use of dietary supplements in the European Prospective Investigation into Cancer and Nutrition calibration study. Eur J Clin Nutr (2009) 1.49
Relationship between questionnaire data and medical records of height, weight and body mass index. Int J Obes Relat Metab Disord (1992) 1.49
Papanicolaou smear screening and cervical cancer. What can you expect? JAMA (1984) 1.48
Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years of follow-up. Calcif Tissue Int (1993) 1.48
Human fertility does not decline: evidence from Sweden. Fertil Steril (1999) 1.47
The eosinophil granule proteins in serum, but not the oxidative metabolism of the blood eosinophils, are increased in cancer. Br J Haematol (1997) 1.47
Importance of bile acids for phospholipid secretion into human hepatic bile. Gastroenterology (1969) 1.47
Ploidy and proliferation patterns in colo-rectal adenocarcinomas related to Dukes' classification and to histopathological differentiation. A flow-cytometric DNA study. Acta Pathol Microbiol Immunol Scand A (1983) 1.46
The effect of female sex hormones on cancer survival. A register-based study in patients younger than 20 years at diagnosis. JAMA (1990) 1.45
Long-term trends in incidence of and mortality from acute myocardial infarction and stroke in women: Analyses of total first events and of deaths in the Uppsala Health Care Region, Sweden. Epidemiology (1996) 1.45
A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer. Br J Cancer (2004) 1.45
Screening for osteopenia and osteoporosis: selection by body composition. Osteoporos Int (1996) 1.45
Colonoscopic surveillance in long-standing total ulcerative colitis--a 15-year follow-up study. Gastroenterology (1990) 1.43
Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK) J Gastroenterol Hepatol (2000) 1.43
Survival and renal function in untreated hypercalcaemia. Population-based cohort study with 14 years of follow-up. Lancet (1987) 1.42
Smoking and cervical intraepithelial neoplasia: nicotine and cotinine in serum and cervical mucus in smokers and nonsmokers. Am J Obstet Gynecol (1988) 1.41
Sonographic dating of pregnancies conceived after contraceptive pill therapy. Ultrasound Obstet Gynecol (1993) 1.41
Melanoma in pregnancy. Lancet (1991) 1.39
Mammographic parenchymal patterns in women receiving noncontraceptive estrogen treatment. Am J Epidemiol (1989) 1.38
Ploidy and proliferation in human bladder tumors as measured by flow-cytofluorometric DNA-analysis and its relations to histopathology and cytology. Cancer (1979) 1.37
Managing climate risk. Science (2001) 1.37
Plasma carotenoids as biomarkers of intake of fruits and vegetables: individual-level correlations in the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Clin Nutr (2005) 1.36
Sexual behavior risk factors associated with bacterial vaginosis and Chlamydia trachomatis infection. Sex Transm Dis (1997) 1.33
Tobacco, alcohol and the risk of gastric cancer by sub-site and histologic type. Int J Cancer (1999) 1.33
Vanilloid (capsaicin) receptors in the rat: distribution in the brain, regional differences in the spinal cord, axonal transport to the periphery, and depletion by systemic vanilloid treatment. Brain Res (1995) 1.32
The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol (1992) 1.32
Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement. Cancer Causes Control (1999) 1.28
Effects of routine one-stage ultrasound screening in pregnancy: a randomised controlled trial. Lancet (1988) 1.28
Improvement of semen and pregnancy rate after ligation and division of the internal spermatic vein: fact or fiction? Br J Urol (1979) 1.27
Natural history of localised prostatic cancer. A population-based study in 223 untreated patients. Lancet (1989) 1.26
Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence. Clin Endocrinol (Oxf) (1998) 1.26
The estrogen receptor family. Curr Opin Obstet Gynecol (1999) 1.26
Nutrients and gastric cancer risk. A population-based case-control study in Sweden. Int J Cancer (1994) 1.25
Energy, nutrient intake and prostate cancer risk: a population-based case-control study in Sweden. Int J Cancer (1996) 1.24
Gallbladder emptying during the normal menstrual cycle. A cholecystographic study. Acta Chir Scand (1967) 1.23
Age at first primary as a determinant of the incidence of bilateral breast cancer. Cumulative and relative risks in a population-based case-control study. Cancer (1985) 1.23
Comparison of excess costs of care and production losses because of morbidity in diabetic patients. Diabetes Care (1994) 1.22
A prospective study of association of monounsaturated fat and other types of fat with risk of breast cancer. Arch Intern Med (1998) 1.22
Gallbladder disease and sex hormones. A statistical study. Acta Chir Scand (1966) 1.21